Cormorant Asset Management
Overview
Cormorant Asset Management is a life sciences and healthcare focused investment firm that primarily invests in public and private biotechnology companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Revolution Medicines | Jul 2019 | Series C | Co-investor |
| Principia | Aug 2018 | Series C | Lead |
| Everest Medicines | Jun 2020 | Series C | Co-investor |
| ELVN-ELVN | Jan 2022 | Series B | Lead |
| Fog Pharmaceuticals | Jan 2026 | Series F | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Cormorant Asset Management based?
Cormorant Asset Management is headquartered in Boston, Massachusetts, United States.
When was Cormorant Asset Management founded?
Cormorant Asset Management was founded in 2013.
How many portfolio companies does Cormorant Asset Management have?
Cormorant Asset Management has 67 portfolio companies in Caplight's dataset.
What are some companies in Cormorant Asset Management's portfolio?
Portfolio companies visible on Caplight include Revolution Medicines, Principia, Everest Medicines, ELVN-ELVN, Fog Pharmaceuticals.
What was Cormorant Asset Management's most recent investment shown here?
Cormorant Asset Management's most recent investment in this portfolio sample was in Fog Pharmaceuticals in 2026.
What sectors does Cormorant Asset Management focus on?
Cormorant Asset Management focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Real Estate & PropTech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure.
What company stages does Cormorant Asset Management focus on?
Cormorant Asset Management typically invests at the Mid stage.
What is Cormorant Asset Management's AUM?
Cormorant Asset Management's assets under management are estimated between $3.8B and $4.0B.